/

Sociétés

Ma

Non vérifié

Massive Bio

Ce que nous écrivons

IndustrieMédecine - DiversMultimédiaOncologieSanté

13 communiqués de presse

Voir tous les communiqués de presse

18/11/2025

Oncologie

Technologies de l'Information

Santé

Technique

Santé Publique

Médecine - Divers

Marché du travail

Industrie

Massive Bio Collaborates with the American Cancer Society to Accelerate Equitable Access to Cancer Clinical Trials

Source

Émetteur

1.00

0

14/11/2025

Massive Bio Announces Reticulum Nexus - an AI-Driven Multi‑Agent Platform Orchestrating the End-to-end Patient Journey

Source

Émetteur

1.00

0

17/10/2025

Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown

Source

Émetteur

1.00

0

28/08/2025

Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching

Source

Émetteur

1.00

0

12/08/2025

Massive Bio and Prognos Health Announce Strategic Partnership to Expand Oncology Access

Source

Émetteur

1.00

0

31/07/2025

MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant

Source

Émetteur

1.00

0

05/06/2025

Massive Bio Recognized in Two Key Categories on CB Insights’ AI Drug Research & Development Market Map

Source

Émetteur

1.00

0

30/05/2025

Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25

Source

Émetteur

1.00

0

14/04/2025

Massive Bio Receives CNIL Certification for GDPR Compliance

Source

Émetteur

1.00

0

11/02/2025

Massive Bio Stands Committed to Accelerating Cancer Research and Clinical Trial Access Amid NIH Funding Uncertainty

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0